Indivior Pharmaceuticals, Inc. INDV 深 滬
已收盤 05-08 16:00:00 美东时间
39.50
-0.100
-0.25%
華盛通- 最 高40.05
- 今 開39.78
- 成交量 248.01万股
- 最 低 39.0101
- 昨 收 39.60
- 總市值 46.69亿
- 52周最高 41.00
- 市盈率 靜 24.08
- 換手率 2.10%
- 52周最低 11.065
- 委 比 30.18%
- 總股本 1.18亿
- 歷史最高 41.00
- 量 比 0.74
- 振 幅 2.63%
- 歷史最低 7.33
- 每 手 1
- 風險率 8.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | Indivior Pharmaceuticals, Inc. 2026财年Q1营收3.17亿美元，同比增长19.2%；归母净利润0.89亿美元，同比增长89.4%
华盛资讯5月1日讯，Indivior Pharmaceuticals, Inc.公布2026财年Q1业绩，公司Q1营收3.17亿美元，同比增长19.2%，归母净利润0.89亿美元，同比增长89.4%。
05-01 04:49
财报速睇 | Indivior Pharmaceuticals, Inc. 2026财年Q1营收3.17亿美元，同比增长19.2%；归母净利润0.89亿美元，同比增长89.4%
华盛资讯4月30日讯，Indivior Pharmaceuticals, Inc.公布2026财年Q1业绩，公司Q1营收3.17亿美元，同比增长19.2%，归母净利润0.89亿美元，同比增长89.4%。
04-30 21:18
Earnings Scheduled For April 30, 2026
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11
Indivior Pharmaceuticals Raises FY2026 Sales Guidance from $1.125B-$1.195B to $1.215B-$1.285B vs $1.156B Est
Indivior Pharmaceuticals (NASDAQ:INDV) raises FY2026 sales outlook from $1.125 billion-$1.195 billion to $1.215 billion-$1.285 billion vs $1.156 billion estimate.
04-30 19:04
Indivior Q1 Adj. EPS $0.96 Beats $0.66 Estimate, Sales $317.000M Beat $272.840M Estimate
Indivior (NASDAQ:INDV) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.66 by 45.45 percent. This is a 134.15 percent increase over earnings of $0.41 per share from the same
04-30 19:02
Indivior Pharmaceuticals Awarded ~$748.9M U.S. Department Of Veterans Affairs Drug Supply Contract, Pharmaceutical Preparation Manufacturing
https://sam.gov/opp/301d35fe03404ac6ad3aec2215c3c893/view
04-27 22:41
Indivior Announces Findings From Retrospective Observational Study Showing Adherence To SUBLOCADE Monthly Injectable Buprenorphine Linked To Lower Healthcare Utilization And Costs In Opioid Use Disorder
Patients adherent to SUBLOCADE® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients adherent to SUBLOCADE had the lowest inpatient, emergency department, and
03-11 21:04
财报速睇 | Indivior Pharmaceuticals, Inc. 2025财年年度营收12.39亿美元，同比增长4.3%；归母净利润2.10亿美元，同比增长2900.0%
华盛资讯2月27日讯，Indivior Pharmaceuticals, Inc.公布2025财年年度业绩，公司年度营收12.39亿美元，同比增长4.3%，归母净利润2.10亿美元，同比增长2900.0%。
02-27 05:51
财报速睇 | Indivior Pharmaceuticals, Inc. 2025财年Q4营收3.58亿美元，同比增长20.1%；归母净利润1.02亿美元，同比增长385.7%
华盛资讯2月26日讯，Indivior Pharmaceuticals, Inc.公布2025财年Q4业绩，公司Q4营收3.58亿美元，同比增长20.1%，归母净利润1.02亿美元，同比增长385.7%。
02-26 21:46
财报速睇 | Indivior Pharmaceuticals, Inc. 2025财年Q4营收3.58亿美元，同比增长20.1%；归母净利润1.02亿美元，同比增长385.7%
华盛资讯2月26日讯，Indivior Pharmaceuticals, Inc.公布2025财年Q4业绩，公司Q4营收3.58亿美元，同比增长20.1%，归母净利润1.02亿美元，同比增长385.7%。
02-26 21:35
